Glymet Tablet 50/850 mg
Sitagliptin Phosphate Hydrate 64.25mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.
MFDS item code 201505750 · Approved 2015.08.18
This product's status changed to Expired on 2025.08.18. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of blood sugar control in type 2 diabetes
This drug is used to improve blood sugar control in patients with type 2 diabetes by assisting with diet and exercise.
This medication is generally taken twice a day with food, gradually increasing the dosage to reduce gastrointestinal adverse reactions caused by metformin. 1. For patients not previously treated with metformin: The initial dose is 50/500 mg of this medication taken twice daily, one tablet at a time, and it can be increased to 50/1000 mg taken twice daily, one tablet at a time. 2. For patients currently receiving metformin...
This drug contains two ingredients, sitagliptin and metformin. Firstly, sitagliptin can rarely cause serious allergic reactions, which may occur within 3 months of taking the medication. If symptoms such as skin rash, difficulty breathing, swelling of the face or lips appear, discontinue this medication immediately and consult a doctor. Additionally, sitagliptin can cause inflammation of the pancreas, known as acute pancreatitis, so if symptoms such as abdominal pain, nausea, or vomiting occur, seek medical attention immediately. Metformin can cause lactic acidosis, a rare but serious metabolic anomaly. This symptom can begin with nonspecific symptoms such as muscle pain, difficulty breathing, severe fatigue, and abdominal pain, so if these symptoms occur, stop taking the medication immediately and visit a hospital. Patients with poor kidney function or liver dysfunction should not take this medication and should undergo regular kidney function tests. This medication is not used in patients with moderate to severe renal impairment, severe infections, heart failure, acute myocardial infarction, severe dehydration, or in pregnant or breastfeeding women. Also, this medication should be temporarily discontinued before using tests that involve iodine contrast agents and should not be resumed until kidney function is confirmed to be normal. There is a risk of hypoglycemia with this medication, so caution is advised if meals are skipped or if exercise suddenly increases, and hypoglycemia symptoms may be more pronounced when used in combination with other antidiabetic agents. While taking this medication, side effects such as diarrhea, nausea, vomiting, headache, and upper respiratory infections may occur, and rarely severe joint pain or skin conditions may arise, so any unusual symptoms should be reported to a doctor. Alcohol can increase the risk of side effects from this medication, so excessive drinking should be avoided while on treatment. Finally, this medication is not recommended for children under 18, pregnant women, or breastfeeding mothers, and elderly patients should have their kidney function monitored regularly while adjusting the dosage. While taking this medication, it is important to regularly check blood sugar levels, kidney function, and vitamin B12 levels, and to consult healthcare professionals immediately if any unusual symptoms arise.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air exposure, at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the efficacy of the medication for a longer period.
Pink oval film-coated tablet
56 tablets (28 tablets/PTP*2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sitagliptin Phosphate Hydrate 64.25mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.
CombinationSitagliptin Phosphate Hydrate 64.25mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Jongkun Dang Co., Ltd.
CombinationSitagliptin Phosphate Hydrate 64.25mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationSitagliptin Phosphate Hydrate 64.25mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Sitagliptin Phosphate Hydrate 64.25mg
Tablet · Prescription medication · Combination
Jong Kun Dang Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Sitagliptin Phosphate Hydrate 64.25mg
Tablet · Prescription medication · Combination
JongKeunDang Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
Sitagliptin Phosphate 62.04mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Yuyu Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.